Anti-SPRED1抗体[M23-P2G3] (ab64740)

发表研究结果有使用 ab64740?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab64740 被引用在 1 文献中.

  • Pasmant E  et al. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia. Oncogene N/A:N/A (2014). PubMed: 24469042

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"